NCT03428880

Brief Summary

Subarachnoid morphine (SAM) is the gold standard for treating postoperative pain after cesarean delivery (CD) but it has undesirable side effects, that's why the aim of our study is to identify whether ultrasound-guided Quadratus lumborum block type 3, a new regional anesthetic technique that blocks the abdominal wall neural afferents, can provide at the same time better postoperative analgesia after CD with less side effects

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Feb 2017

Shorter than P25 for phase_4

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2017

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 5, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 12, 2018

Completed
Last Updated

February 14, 2018

Status Verified

February 1, 2018

Enrollment Period

8 months

First QC Date

February 5, 2018

Last Update Submit

February 12, 2018

Conditions

Keywords

quadratus lumborum blockcesarean sectionspinal morphineultrasound guidance

Outcome Measures

Primary Outcomes (1)

  • Total morphine consumption over 24 hours postoperatively

    Total IV morphine used when started postoperatively using a PCA with morphine in the post anesthesia care unit until 2' hours posteratively.

    Arrival to post anesthesia care unit until 24 hours posteratively

Secondary Outcomes (3)

  • Time to first analgesic demand using PCA pump with morphine

    Arrival to post anesthesia care unit until 24 hours posteratively

  • Visual analog scale (VAS) pain scores at rest and during the palpation of the uterine globe

    Arrival to post anesthesia care unit until 24 hours posteratively

  • Time to first deambulaton after surgery

    Arrival to post anesthesia care unit until 24 hours posteratively

Study Arms (2)

spinal morphine

ACTIVE COMPARATOR

intrathecal morphine with 10 mg bupivacaine, 5 gamma sufenta and 100 gamma morphine. Intervention: In the end of surgery a QLB block is done with 20 ml of normal saline per side.

Drug: Morphine

quadratus lumborum block

ACTIVE COMPARATOR

intrathecal anesthesia with10 mg bupivacaine, 5 gamma sufena and 1 ml normal saline. Procedure : a quadratus lumborum block is done with 20 ml of bupivacaine 0,125% per side.

Drug: Quadratus lumborum block

Interventions

spinal morphine is done before cesarean section

Also known as: spinal morphine
spinal morphine

a US Block QLB is done after surgery

Also known as: QLB
quadratus lumborum block

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • ASA I/II.
  • Normal singleton pregnancy with a gestation of at least 37 weeks.

You may not qualify if:

  • Heart disease
  • Coagulopathy
  • pre-eclampsia
  • BMI\> 40
  • Patient refusal to undergo the Quadratus lumborum block.
  • Allergy to local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Tunis maternity and neonatology center, minisetry of public health

Tunis, 1007, Tunisia

Location

Tunis maternity and neonatology center,

Tunis, 1007, Tunisia

Location

MeSH Terms

Conditions

Bites and Stings

Interventions

Morphine

Condition Hierarchy (Ancestors)

PoisoningChemically-Induced DisordersWounds and Injuries

Intervention Hierarchy (Ancestors)

Morphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Officials

  • Hayene Maghrebi, Professor

    tunis maternity center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, assistant professor

Study Record Dates

First Submitted

February 5, 2018

First Posted

February 12, 2018

Study Start

February 15, 2017

Primary Completion

September 30, 2017

Study Completion

October 20, 2017

Last Updated

February 14, 2018

Record last verified: 2018-02

Locations